In breast and prostate cancers, where local PRL production has been demonstrated, its proliferative potential via an autocrine/paracrine mechanisms has been proposed to contribute to tumor development and progression [2], [3], [4], [5], [6], [7]. This evidence concerns the gene PRL and neoplasm.